Calcilytix Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Calcilytix Therapeutics's estimated annual revenue is currently $2.8M per year.(i)
  • Calcilytix Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Calcilytix Therapeutics has 18 Employees.(i)
  • Calcilytix Therapeutics grew their employee count by 13% last year.

Calcilytix Therapeutics's People

NameTitleEmail/Phone
1
DirectorReveal Email/Phone
2
Director - Drug Substance Development and Manfacturing (Calcilytix and MLBio)Reveal Email/Phone
3
Director, Analytical DevelopmentReveal Email/Phone
4
Senior Clinical Trial ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Calcilytix Therapeutics?

Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on developing a targeted therapy for disorders of calcium homeostasis. Our product candidate, encaleret, is an investigational orally-administered small molecule designed to specifically inhibit the calcium-sensing receptor, hypothesized to restore normal serum calcium and lower urine calcium.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M186%$38.3M
#2
$0.6M18-5%$88.5M
#3
$1.7M180%N/A
#4
$1.4M18-44%$37.8M
#5
$1.6M18-10%N/A